Risdiplam
Risdiplam is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including EVRYSDI. Available dosage forms: powder, for solution, tablet, powder.
Drug Details
- Generic Name
- Risdiplam
- Brand Names
- EVRYSDI
- Application Number
- NDA213535
- Sponsor
- Genentech, Inc.
- NDC Codes
- 3
- Dosage Forms
- POWDER, FOR SOLUTION, TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- RISDIPLAM
Indications and Usage
1 INDICATIONS AND USAGE EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. EVRYSDI is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. ( 1 )